TAM
CHRS icon

THB Asset Management’s Coherus Oncology CHRS Stock Holding History

THB Asset Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.77M Sell
101,790
-11,364
-10% -$202K 0.4% 84
2020
Q3 		$2.08M Sell
113,154
-7,561
-6% -$141K 0.58% 65
2020
Q2 		$2.15M Buy
+120,715
New +$2.04M 0.62% 66

Other funds holding CHRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

THB Asset Management's CHRS Position: Q4 2020 in Review

THB Asset Management reduced its Coherus Oncology (CHRS) stake by 10% in Q4 2020, selling an estimated $202K and leaving 101,790 shares worth $1.77M. The position accounts for 0.4% of the portfolio, ranked #84.

THB Asset Management first reported a position in CHRS in Q2 2020 and has held it in 3 quarters since. The position peaked at $2.15M in Q2 2020. 196 funds tracked by Wall St. Rank hold CHRS as of Q4 2020.

  • THB Asset Management held 101,790 shares of Coherus Oncology worth $1.77M as of Q4 2020.
  • THB Asset Management sold 11,364 Coherus Oncology shares in Q4 2020, an estimated $202K.
  • Coherus Oncology made up 0.4% of THB Asset Management's portfolio in Q4 2020, its #84 holding.
  • THB Asset Management first reported a position in Coherus Oncology in Q2 2020 and has held it in 3 quarters since.
  • THB Asset Management's Coherus Oncology position peaked at $2.15M in Q2 2020.
  • 196 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2020.

Based on THB Asset Management's 13F filing for Q4 2020, filed 5 Feb 2021.